Live feed
Filing
SC 13D/A
SC 13D/A0001144204-18-057334·Inhibitor Therapeutics, Inc.
Schedule 13D ownership disclosure
HedgePath Pharmaceuticals, Inc.
Security class unavailable
Event date: 2018-11-02
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 247,697,328
- Percent of class
- 59.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-18-057334
- Form type
- SC 13D/A
- Filer
- Inhibitor Therapeutics, Inc.
- CIK
- CIK 1042418
- Filed
- Nov 05, 2018
- Reporting period
- Nov 02, 2018
- Description
- Schedule 13D beneficial ownership